Corporate Overview
Ichnos Glenmark Innovation is an alliance between Ichnos Sciences, a global fully-integrated clinical-stage biotech company developing Multispecifics™ in oncology and Glenmark Pharmaceuticals, an integrated, research-led global pharmaceuticals company.
Explore our Corporate Overview
Download a copy to learn more about Ichnos Glenmark Innovation
Explore our Corporate Overview
Download a copy to learn more about Ichnos Glenmark Innovation and how it has been combining forces to transform the world of oncology, one molecule at a time.